Table 3.
FGFR | Partner | Cancer Subtype | Consequence of Interaction | Associated References |
---|---|---|---|---|
FGFR1 | Anosmin-1 | Brain; Glioblastoma | Promotes motility and invasion in FGFR-dependent manner | [259] |
Collagen type IV | Pancreatic | Sustained ERK1/2 activation | [10,176,177,260] | |
EGFR | Lung | Increases AKT and STAT3 signaling | [261] | |
EPHA4 | Glioma | Potentiates FGFR1-signaling | [262] | |
Galectin-1 | Osteosarcoma | Activated FGFR1, increased proliferation and survival | [263] | |
Galectin-3 | Osteosarcoma | FGFR1 plasma membrane clustering | [263] | |
GALNT14 | Breast | Promotes FGFR activation | [264] | |
Integrin-αVβ3 | Breast | Increased tumorigensis, angiogenesis and EMT | [265,266] | |
Integrin-β3 | Breast | Disrupts colocalization with E-cadherin and promotes EMT | [267] | |
L1CAM | Glioma | Promote motility and proliferation | [268,269] | |
N-cadherin | Breast | Stabilizes FGFR1 at plasma membrane, promoting sustained ERK1/2 signal, increased invasion, motility and metastasis | [270,271] | |
NRP1 | Breast | FGFR1-NRP1 complex increases during EMT | [272] | |
RET-KIF5B, EGFR | RET-KIF5B fusion positive cancers | Increases FGFR activation and promotes inavdopodia formation | [273] | |
TGFBR3 | Neuroblastoma | Activates ERK1/2 signaling, promoting differentiation, suppressing tumor growth and metastasis | [274] | |
FGFR2 | EGFR | Breast | Induces EGFR T693 phosphorylation, recycling and stabilization and increases cell cycle outputs | [275] |
EPHA4 | Glioma | Increases proliferation and migration | [262] | |
RET-KIF5B, EGFR | RET-KIF5B fusion positive cancers | Increases FGFR activation and promotes inavdopodia formation | [273] | |
FGFR3 | PYK2 | Multiple myeloma | Increases STAT5 activation | [276] |
TAK1 | Multiple myelomaBladder | Cell adhesion and NFκB-dependent transcription | [277] | |
FGFR4 | NCAM | Pancreatic | Promote neurite outgrowth | [278] |
NCAM | Pituitary neoplasia | When interaction is inhibited increases invasive phenotype | [279] |
EGFR, epidermal growth factor receptor; EMT, epithelial-mesenchymal transition; EPHA4, ephrin type A receptor 4; ERK1/2, extracellular signal-regulated protein kinase 1/2; FGFR, fibroblast growth factor receptor; L1CAM, L1 cell adhesion molecule; GALNT14, polypeptide N-acetyl galactosaminyltransferase 14; NFκB, nuclear factor κB; NRP1, neuropilin 1; PYK2, focal adhesion nonreceptor protein tyrosine kinase 2; RET-KIF5B, rearranged during transfection (RET)-kinesin family member 5B (KIF5B); STAT3/5; signal transducer and activator of transcription 3/5; TAK1, transforming growth factor α-activated kinase 1; TGFBR3, transforming growth factor receptor β; T693, threonine 693.